BELITE BIO, INC (BLTE) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$36.99M | -26.5% |
| 2024 | -$29.23M | +2.0% |
| 2023 | -$29.84M | -160.4% |
| 2022 | -$11.46M | -53.3% |
| 2021 | -$7.47M | -68.3% |
| 2020 | -$4.44M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$36.99M | -26.5% |
| 2024 | -$29.23M | +2.0% |
| 2023 | -$29.84M | -160.4% |
| 2022 | -$11.46M | -53.3% |
| 2021 | -$7.47M | -68.3% |
| 2020 | -$4.44M | — |